login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
RECURSION PHARMACEUTICALS-A (RXRX) Stock News
USA
- NASDAQ:RXRX -
US75629V1044
-
Common Stock
4.72
USD
+0.09 (+1.94%)
Last: 9/26/2025, 8:00:02 PM
4.7199
USD
0 (0%)
After Hours:
9/26/2025, 8:00:02 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
RXRX Latest News, Press Relases and Analysis
All
Press Releases
11 hours ago - By: The Motley Fool
- Mentions:
LLY
NVDA
Where Will Recursion Pharmaceuticals Be in 5 Years?
12 hours ago - By: The Motley Fool
The Biotech Stock That's Too Risky for Most Investors
3 days ago - By: Benzinga
- Mentions:
RSG
BROS
ABTC
Jim Cramer Says This Financial Stock Is A 'Total Spec,' Likes Dutch Bros,
18 days ago - By: Benzinga
What Analysts Are Saying About Recursion Pharmaceuticals Stock
13 days ago - By: Zacks Investment Research
Recursion Pharmaceuticals (RXRX) Stock Sinks As Market Gains: What You Should Know
a month ago - By: Yahoo Finance
Recursion Pharmaceuticals, Inc. (RXRX) Expands Rare Disease Pipeline with REV102 Acquisition
a month ago - By: Recursion Pharmaceuticals
Recursion to Participate in Upcoming Investor Conferences
a month ago - By: Yahoo Finance
- Mentions:
NVDA
1 Reason to Buy This Beaten-Down Artificial Intelligence (AI) Stock, and 2 Reasons to Sell
a month ago - By: Yahoo Finance
- Mentions:
MS
Why Recursion Pharmaceuticals Stock Caught a Cold This Week
a month ago - By: Yahoo Finance
Recursion Pharmaceuticals (RXRX) Drops on 3rd Day as Company Execs Dispose of Shares
a month ago - By: Yahoo Finance
- Mentions:
RLYB
Recursion Pharmaceuticals (RXRX) Expands AI Drug Discovery Pipeline with New Clinical Candid
a month ago - By: Yahoo Finance
- Mentions:
NVDA
AMZN
MSFT
BAC
...
Nvidia quietly buys more stock in AI infrastructure favorite
2 months ago - By: Zacks Investment Research
- Mentions:
CRMD
ARVN
IMCR
RXRX Q2 Loss Wider Than Expected, Revenues Rise Y/Y, Stock Down
2 months ago - By: Yahoo Finance
Why Recursion Pharmaceuticals Stock Tanked on Tuesday
2 months ago - By: Zacks Investment Research
- Mentions:
MRSN
Recursion Pharmaceuticals (RXRX) Reports Q2 Loss, Beats Revenue Estimates
2 months ago - By: Recursion Pharmaceuticals
Recursion Reports Second Quarter 2025 Financial Results and Provides Business Update
2 months ago - By: Recursion Pharmaceuticals
Recursion Reports Second Quarter 2025 Financial Results and Provides Business Update
2 months ago - By: Zacks Investment Research
- Mentions:
ZTS
ACAD
Recursion Pharmaceuticals to Report Q2 Earnings: What's in the Cards?
2 months ago - By: Yahoo Finance
- Mentions:
VKTX
2 Beaten-Down Stocks With Incredible Upside Potential
2 months ago - By: Recursion Pharmaceuticals
Recursion to Report Second Quarter 2025 Business Updates and Financial Results on August 5th
Please enable JavaScript to continue using this application.